CHE Chemed Corporation

VITAS HEALTHCARE PRESENTS AT AMERICAN COLLEGE OF EMERGENCY PHYSICIANS’ 50th ANNIVERSARY SCIENTIFIC ASSEMBLY

VITAS HEALTHCARE PRESENTS AT AMERICAN COLLEGE OF EMERGENCY PHYSICIANS’ 50th ANNIVERSARY SCIENTIFIC ASSEMBLY

Miami, FL, Oct. 02, 2018 (GLOBE NEWSWIRE) -- October 2, 2018— VITAS® Healthcare, the nation’s leading provider of end-of-life care, is participating in the American College of Emergency Physicians’ (ACEP) scientific assembly beginning October 1 in San Diego, California. This year’s meeting marks the 50th anniversary of the organization, whose members are committed to providing the highest quality, compassionate emergency care.

 

The , like those nearing the end of life, presents EDs with an obstacle to productive workflow and outcome goals.

 

“The partnership between a hospice provider and emergency physicians is critical in transitioning end-of-life patients to a more appropriate secondary site of care,” said Eric Shaban, MD, VITAS Regional Medical Director. “VITAS is committed to working with emergency departments to reduce the number of unnecessary hospital readmissions and easing the burden on EDs and elevating patient satisfaction. We look forward to future collaborations that will make every moment count.”

 

Below is the schedule of sessions hosted by VITAS physicians:

 

  • Dr. Shaban presents ACEP’s Acute Unscheduled Care Model Enhancing Appropriate Admissions with the Help of Hospice
    • Monday, Oct. 1 from 11 a.m. – 1 p.m.
    • Manchester Grand Hyatt San Diego
  • InnovatED Spotlight: VITAS physician Dr. Eric Shaban and ACEP member physicians Dr. David Wang and Dr. Eric Isaacs discuss “Improving Work Flow for Hospice-Eligible Patients Presenting to the ED”
    • Tuesday, Oct. 2 from 2:30 – 2:45 p.m.
    • San Diego Convention Center, Innovation Stage – Booth #1543

 

VITAS physicians Dr. Shaban and Dr. Wright as well as VITAS representatives will be to answer questions about hospice and discuss VITAS’ role in emergency care. Light refreshments will be served in addition to a special visit from VITAS Paw Pals®. Attendees can also enter a raffle for a chance to win a $250 gift card toward any airline flight.

 

VITAS offers personalized end-of-life care plans that improve patients’ quality of life, resulting in higher CAHPS® scores. VITAS’ longitudinal care continuum has proven to reduce 911 calls, emergency department visits, critical care unit utilization, hospital readmissions, medication spend and length of stay. To learn more about the role of hospice in the continuum of care, and the role of health plans in improving access, visit .

 

 

VITAS Healthcare – 40 Years Strong

Established in 1978, VITAS Healthcare is a pioneer and leader in the American hospice movement. Headquartered in Miami, Florida, VITAS (pronounced VEE-tahs) operates 47 hospice programs in 14 states (California, Connecticut, Delaware, Florida, Georgia, Illinois, Kansas, Missouri, New Jersey, Ohio, Pennsylvania, Texas, Virginia and Wisconsin) and the District of Columbia. VITAS employs 11,914 professionals who care for terminally ill patients daily, primarily in the patients’ homes and also in the company’s 28 inpatient hospice units as well as in hospitals, nursing homes and assisted living communities/residential care facilities for the elderly. At the conclusion of the second quarter of 2018, VITAS reported an average daily census of 17,739. Visit .

Attachments

Claudia Quintana
VITAS Healthcare
877-848-2701
 
EN
02/10/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Chemed Corporation

 PRESS RELEASE

Chemed Reports Fourth-Quarter 2025 Results

Chemed Reports Fourth-Quarter 2025 Results CINCINNATI, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its fourth quarter ended December 31, 2025, versus the comparable prior-year period. Results for Quarter Ended December 31, 2025 Consolidated operating results: Revenue was $639.3 million, essentially flat with the...

 PRESS RELEASE

Chemed Corporation Board of Directors Authorizes an Additional $300 Mi...

Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 60 Cents CINCINNATI, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $300 million for stock repurchase under Chemed’s existing share repurchase program. These share repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility. The Board of Directors has declared a quarterly cash divide...

 PRESS RELEASE

Chemed to Report Fourth-Quarter 2025 Earnings February 25, Related Con...

Chemed to Report Fourth-Quarter 2025 Earnings February 25, Related Conference Call to Be Held on February 26 CINCINNATI, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2025, on Wednesday, February 25, 2026, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Thursday, February 26, 2026, to discuss the company's quarterly results and to provide an update on its business. Participants may access a li...

 PRESS RELEASE

Chemed Corporation to Present at the BofA Securities 2025 Virtual Home...

Chemed Corporation to Present at the BofA Securities 2025 Virtual Home Care Conference CINCINNATI, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) today announced that it will present at the BofA Securities 2025 Virtual Home Care Conference on Tuesday, December 9, 2025, at 1:20 PM (ET). The presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at (Investor Relations). The webcast replay will be available within 24 hours of the live presentation and will be accessible for 90 days. Listed on the New York S...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch